Substrate specificity and in vivo efficacy of engineered cocaine esterases toward cocaine and its toxic metabolites
- 16 April 2026
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 433, 112088
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82073749)
- National Natural Science Foundation of China (82574306)
- Hangzhou Normal University (2025JCXK02)
- Hangzhou Normal University (2025ZY01109)
- National Science and Technology Major Project (2022ZD0214600)
This publication has 42 references indexed in Scilit:
- Computational Design and Crystal Structure of a Highly Efficient Benzoylecgonine HydrolaseAngewandte Chemie International Edition, 2021
- In vivo characterization of toxicity of norcocaethylene and norcocaine identified as the most toxic cocaine metabolites in male miceDrug and Alcohol Dependence, 2019
- Evaluation of the cholinesterase activity of a potential therapeutic cocaine esterase for cocaine overdoseDrug and Alcohol Dependence, 2019
- The importance of considering polysubstance use: lessons from cocaine researchDrug and Alcohol Dependence, 2018
- Effects of a cocaine hydrolase engineered from human butyrylcholinesterase on metabolic profile of cocaine in ratsChemico-Biological Interactions, 2016
- Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependenceDrug and Alcohol Dependence, 2016
- Safety, pharmacokinetics, and pharmacodynamics of TV‐1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjectsThe Journal of Clinical Pharmacology, 2015
- Cocaine IntoxicationCritical Care Clinics, 2012
- Cocaine and benzoylecgonine constrict cerebral arteries by different mechanismsLife Sciences, 1995
- Effect of cocaine and cocaine metabolites on cerebral arteries in vitroLife Sciences, 1990